Melanoma March has officially launched
5 February 2015
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
The launch event held at Tonic House in Melbourne’s CBD revealed plans for the new funding. There will be 23 marches that are happening around Australia, with the first march kicking off in Melbourne on the 22nd February.
Professor Graham Mann, Research Director at MIA, explained how the Melanoma March campaign provides critical funding for our expert clinicians to get one step closer to finding a cure. He revealed the beneficiary of the 2015 initiative will be the next phase of the Melanoma Genome Project.
“Monies raised from last year’s Melanoma March campaign contributed to the world-first PD-1 Brain Metastases Trial - that is currently underway,” he said.
“Half of all patients diagnosed with stage 4 melanoma will develop brain metastases at some point during their illness. Until now, treatment has been unavailable and as such the clinicians at Melanoma Institute Australia are committed to developing new treatment options that provide potential hope to patients with brain metastases and could prove to be a significant step in finding a cure.
“Funds raised from the 2015 Melanoma March campaign will enable Melanoma Institute Australia and melanoma research centres around the nation to work together to launch a study which hopes to enable melanoma cells to be isolated, banked, distributed and tested against new treatments. This approach is a powerful way to capitalise on new knowledge from gene and immunity analysis that is showing where melanoma is vulnerable to attack.
Known as ‘Australia’s national cancer’, Australia has the highest incidence of melanoma in the world with over 12,500 new cases diagnosed each year, equating to one person dying every six hours from melanoma in Australia. Sadly, melanoma kills more young Australians (15-39 year-olds) than any other single cancer, proving why continual funding for research is key in addressing this devastating illness.
The Melbourne launch was also attended by former AFL icon and melanoma survivor, Tim McGrath as well as award winning musician Bob Corbett and channel Ten news presenter Brad McEwen.
To see where your local march is and how you can get involved to help us raise $1 million for melanoma research click here.
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.